Articles with "migraine adults" as a keyword



Photo from wikipedia

Fremanezumab for prophylaxis of migraine in adults

Sign Up to like & get
recommendations!
Published in 2020 at "Prescriber"

DOI: 10.1002/psb.1818

Abstract: Fremanezumab (Ajovy) is a new anti‐CGRP monoclonal antibody therapy indicated for the prophylaxis of migraine in adults. This article outlines its properties, efficacy, adverse effects and place in therapy. read more here.

Keywords: migraine adults; prophylaxis migraine; fremanezumab prophylaxis;
Photo from wikipedia

Galcanezumab: First Global Approval

Sign Up to like & get
recommendations!
Published in 2018 at "Drugs"

DOI: 10.1007/s40265-018-1002-7

Abstract: Galcanezumab-gnlm (Emgality™; Eli Lilly and Company), hereafter galcanezumab, is a humanized monoclonal antibody against the calcitonin gene-related peptide (CGRP) ligand. A potent vasodilator, CGRP is implicated in nociceptive transmission and migraine pathogenesis. In September 2018,… read more here.

Keywords: migraine; galcanezumab; galcanezumab first; migraine adults ... See more keywords
Photo by franganillo from unsplash

Comment on ‘Efficacy and feasibility of antidepressants for the prevention of migraine in adults: a meta‐analysis’

Sign Up to like & get
recommendations!
Published in 2017 at "European Journal of Neurology"

DOI: 10.1111/ene.13383

Abstract: have read the paper entitled ‘Efficacy and feasibility of antidepressants for the prevention of migraine in adults: a meta-analysis’ [1] written by Xu et al. which was published in the European Journal of Neurology in… read more here.

Keywords: neurology; migraine; antidepressants prevention; migraine adults ... See more keywords
Photo by franganillo from unsplash

Once-monthly galcanezumab for the prevention of migraine in adults: an evidence-based descriptive review and potential place in therapy

Sign Up to like & get
recommendations!
Published in 2019 at "Therapeutics and Clinical Risk Management"

DOI: 10.2147/tcrm.s159690

Abstract: In the last 15 years relevant efforts have been made to demonstrate that calcitonin gene-related peptide (CGRP) antagonism is a valuable and druggable mechanism for treatment or prevention of migraine. Galcanezumab is one of the… read more here.

Keywords: prevention migraine; monthly galcanezumab; migraine adults; migraine ... See more keywords
Photo by drew_hays from unsplash

Medical Cannabis for the Treatment of Migraine in Adults: A Review of the Evidence

Sign Up to like & get
recommendations!
Published in 2022 at "Frontiers in Neurology"

DOI: 10.3389/fneur.2022.871187

Abstract: Background Medical cannabis (MC) has been hypothesized as an alternative therapy for migraines, given the undesirable side effects of current migraine medications. The objective of this review was to assess the effectiveness and safety of… read more here.

Keywords: treatment migraine; migraine; medical cannabis; migraine adults ... See more keywords